Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 5, 2011, Pages 751-759

  Enkelmann, Astrid ^a   Heinzelmann, Joana ^a   Von Eggeling, Ferdinand ^a   Walter, Martina ^a   Berndt, Alexander ^a   Wunderlich, Heiko ^a   Junker, Kerstin ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Bladder carcinoma; Cell culture; MicroRNA; Proteomics; Tumour associated fibroblasts

Indexed keywords

MICRORNA;

ARTICLE; BLADDER CANCER; CELL ISOLATION; CONTROLLED STUDY; EPIGENETICS; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PREPUCE; PRIORITY JOURNAL; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ANTIGENS, THY-1; CELL LINE, TUMOR; FIBROBLASTS; HUMANS; MICRORNAS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; URINARY BLADDER NEOPLASMS;

EID: 79955685403     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0932-6     Document Type: Article

References (35)

1. Bar-Joseph Z, Siegfried Z, Brandeis M, Brors B, Lu Y, Eils R et al (2008) Genome-wide transcriptional analysis of the human cell cycle identifies genes differentially regulated in normal and cancer cells. Proc Nation Acad Sci 105:955-960 (Pubitemid 351282063)
2. Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432:332-337 (Pubitemid 39551661)
3. Busch A, Michel S, Hoppe C, Driesch D, Claussen U, von Eggeling F (2005) Proteome analysis of maternal serum samples for trisomy 21 pregnancies using proteinchip arrays and bioinformatics. J Histochem Cytochem 53:341-343 (Pubitemid 40344070)
4. Cattan N, Rochet N, Mazeau C, Zanghellini E, Mari B, Chauzy C et al (2001) Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors. Br J Cancer 85:1412-1417 (Pubitemid 33081941)
5. Cummins JM, Velculescu VE (2006) Implications of micro-RNA profiling for cancer diagnosis. Oncogene 25:6220-6227 (Pubitemid 44527853)
6. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R et al (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69:4851-4860
7. Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3:453-458
8. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H et al (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14:518-527 (Pubitemid 351655218)
9. Hu M, Polyak K (2008) Microenvironmental regulation of cancer development. Curr Opin Genet Dev 18:27-34 (Pubitemid 351694443)
10. Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, Sabbioni S et al (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065-7070 (Pubitemid 41161233)
11. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6:392-401
12. Knowles MA (2006) Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 27:361-373
13. Kunz-Schughart LA, Knuechel R (2002) Tumor-associated fibroblasts (part I): active stromal participants in tumor development and progression? Histol Histopathol 17:599-621
14. Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N et al (2009) Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 9:293-301
15. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834-838 (Pubitemid 40839735)
16. Mueller MM, Fusenig NE (2004) Friends or foes [mdash] bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839-849 (Pubitemid 39472951)
17. Nazareth MR, Broderick L, Simpson-Abelson MR, Kelleher RJ Jr, Yokota SJ, Bankert RB (2007) Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. J Immunol 178:5552-5562 (Pubitemid 46674350)
18. Neely LA, Rieger-Christ KM, Neto BS, Eroshkin A, Garver J, Patel S et al (2008) A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 28:39-48
19. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA (2009) MicroRNAs [mdash] the micro steering wheel of tumour metastases. Nat Rev Cancer 9:293-302
20. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59:5002-5011 (Pubitemid 29472907)
21. Östman A, Augsten M (2009) Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr Opin Genet Dev 19:67-73
22. Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M et al (2008) No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 40:650-655 (Pubitemid 351601206)
23. Ruault M, van der Bruggen P, Brun ME, Boyle S, Roizes G, De Sario A (2002) New BAGE (B melanoma antigen) genes mapping to the juxtacentromeric regions of human chromosomes 13 and 21 have a cancer/testis expression profile. Eur J Hum Genet 10:833-840 (Pubitemid 36054565)
24. Rumpold H, Mascher K, Untergasser G, Plas E, Hermann M, Berger P (2002) Trans-differentiation of prostatic stromal cells leads to decreased glycoprotein hormone alpha production. J Clin Endocrinol Metab 87:5297-5303 (Pubitemid 35316377)
25. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjot L et al (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68:6416-6424
26. Seifert HH, Meyer A, Cronauer MV, Hatina J, Muller M, Rieder H et al (2007) A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder. World J Urol 25:297-302
27. Sorrentino A, Liu C-G, Addario A, Peschle C, Scambia G, Ferlini C (2008) Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 111:478-486
28. Uchiyama S, Itoh H, Naganuma S, Nagaike K, Fukushima T, Tanaka H et al (2007) Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers. Gut 56:215-226
29. Urbich C, Kuehbacher A, Dimmeler S (2008) Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79:581-588
30. Wang X, Tang S, Le S-Y, Lu R, Rader JS, Meyers C et al (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 3:e2557
31. Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V et al (2001) A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15:837-846
32. Yang G, Rosen DG, Zhang Z, Bast RC, Mills GB, Colacino JA et al (2006) The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Nation Acad Sci 103:16472-16477 (Pubitemid 44715220)
33. Zhang B, Pan X, Cobb GP, Anderson TA (2007) MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302:1-12 (Pubitemid 46096921)
34. Zhang C, Fu L, Fu J, Hu L, Yang H, Rong T-H et al (2009) Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clin Cancer Res 15:4017-4027
35. Zhong L, Roybal J, Chaerkady R, Zhang W, Choi K, Alvarez CA et al (2008) Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment. Cancer Res 68:7237-7245